Quotes: US MENA   Enter Symbol: NewsLetter: Search: advanced

Experts in Africa cautious on potential malaria vaccine  Join our daily free Newsletter

MENAFN - AFP - 08/10/2013
No. of Ratings : 0
Add to Mixx!



(MENAFN - AFP) Experts in Africa, the continent worst-hit by malaria, reacted with optimism but also caution on Tuesday to news that the first vaccine against the killer disease may soon reach the market.

GlaxoSmithKline said it was seeking approval for a prototype vaccine that reduced the risk of malaria by almost half among children aged between five and 17 months, and by around a quarter among infants aged between six and 12 weeks.

"This is the first vaccine against malaria," Sophie Biernaux, a malaria vaccine leader at GSK, told AFP in Durban.

If the British drugmaker's application is successful, the vaccine could be rolled out within two years.

The mosquito-borne disease kills an estimated 660,000 people each year, 90 percent of them in Africa, with the majority being children under five.

"This is great hope for Africa," Nilton Saraivo, a manager of Angola's national anti-malaria programme, told AFP.

But others were more cautious.

In Gabon, one of the countries where clinical trials were conducted, researcher Bertrand Lell said the vaccine's efficacy "is not very large" compared to vaccines such as the one against polio.

"But given the prevalence of malaria in Africa, you can imagine the impact it will have on people if the mortality rate is down 50 percent," said Lell, of the Lambarene Centre for Medical Research.

In the Democratic Republic of Congo -- which has the world's second-highest malaria death rate after Nigeria -- SANRU, an organisation that distributes mosquito nets to fight malaria, said it was too early to declare victory.

It noted that the vaccine did not offer a complete shield, although trials -- including assessment of a booster shot -- are ongoing.

"This is good news as long as the vaccine shows a required level of efficacy," said John Gikapa, technical advisor to SANRU.

The research was carried out at 11 centres in seven African countries, covering more than 15,000 infants and children.

GSK said it would now file an application to the European Medicines Agency (EMA) under a process aimed at marketing new drugs for poorer countries.

The European medications watchdog will then give a "scientific opinion" on the vaccine's safety and efficacy.

This opens the way for it to be considered by the World Health Organisation (WHO), which in turn can fast-track its licensing in individual countries in Africa.

The vaccine -- called RTS,S -- is a frontrunner in the race to develop the first immunisation for malaria.

The results for the Phase III trial were unveiled Tuesday at a conference in South Africa.

They are sure to raise as many questions as answers.

As well as offering less protection for very small children, the vaccine's effectiveness declined over time, data showed.

"There are a number of possible hypotheses for these differences" in effectiveness, said Lucas Otieno of the Kenya Medical Research Institute, one of the principal investigators in the trial.

The theories include possible interference with the vaccine by maternal antibodies and the impact of other vaccines administered around the same time, he said.

'Any progress welcome'

Experts are also wary about the logistics of administering the vaccine in Africa, where the people most at risk often live in poverty-stricken and difficult-to-access places.

Just getting drugs to where they are needed can be a headache, requiring proper handling in hot, humid environments and secure storage in countries where theft or corruption may be rampant.

"Any progress on fighting malaria is very welcome, and this vaccine could be another important weapon in our armoury," said Martin de Smet, a malaria specialist with Doctors Without Borders (MSF).

"Delivering injection-based vaccines in the kind of environments where malaria is prominent is also hugely challenging -- even for treatments that are 100-percent effective," he said.

"Locations are traditionally remote, with people having to walk for days to get to a health facility, and often require refrigeration."

GSK said if it gets the green light, the vaccine would probably be distributed through agencies such as the United Nations Children's Fund and the GAVI Alliance, a public-private health partnership.

The price would cover the cost of manufacturing plus a margin of five percent which would be ploughed into research for next-generation vaccines, a GSK spokesman said.


 






  MENA News Headlines
 Aug 22 2014 - Saudi - Agriculture sector advances 1.3Arab News
(MENAFN - Arab News) The Saudi stock market continued its positive movement and managed a fourth straight rise on Wednesday accumulating more than 56 points.The Tadawul All-Share Index (TASI) set out ...

 Aug 22 2014 - 20 Most Popular Family Cruise ShipsConsumer Reviews Reveal Most Popular Cruise ShipsMENAFN Press
(MENAFN Press) Built in 2009 the Oasis of the Seas and her sister ship the Allure of the Seas are the largest cruise ships afloat. At a cost of $1.4 billion apiece these floating palaces weigh about ...

 Aug 22 2014 - The Diabetes Protocol ReviewDoes Dr. Kenneth Pullmans Program WorkMENAFN Press
(MENAFN Press) Read Dr. Kenneth Pullman's Diabetes Protocol review and find out if it really treats diabetes and promotes a healthier lifestyle. A 100% natural treatment With no use of drugs and ...

 Aug 22 2014 - Hollande: France armed Syrian rebels 'a few months ago'Arab News
(MENAFN - Arab News) SAINT-PIERRE France: President Francois Hollande said on Thursday that France had delivered weapons to rebels battling the Syrian regime of Bashar Assad 'a few months ago.'The ...

 Aug 22 2014 - Europeans in push for new UN resolution on GazaArab News
(MENAFN - Arab News) UNITED NATIONS: Britain France and Germany have put forward key points of a new UN Security Council resolution on Gaza in a fresh bid to end six weeks of violence diplomats said ...

 Aug 22 2014 - Saudi - Woman kicked fined for trying to enter giraffe penArab News
(MENAFN - Arab News) MILWAUKEE: A California woman who got kicked in the face after trying to climb into the giraffe exhibit at a Madison zoo has paid a fine and apologized.Police say 24-year-old ...

 Aug 22 2014 - Ice Bucket Challenge injures firefighters in USArab News
(MENAFN - Arab News) WASHINGTON: Four US firefighters were injured two seriously Thursday as they were helping run a so-called Ice Bucket Challenge at a Kentucky university.'We express heartfelt ...

 Aug 22 2014 - Asian shares slip as China manufacturing data weighsArab News
(MENAFN - Arab News) HONG KONG: Asian markets mostly fell with downbeat Chinese manufacturing data dragging down Hong Kong and Shanghai as concerns grew about the pace of recovery in the world's ...

 Aug 22 2014 - Saudi - Street car cleaners in the capital feel the heatArab News
(MENAFN - Arab News) Authorities have stepped up the campaign against car cleaners operating illegally on the city's streets.Four Bangladeshis who had been scouring Riyadh's Al-Ahsa Road in search of ...

 Aug 22 2014 - Saudi - No Zamzam hassle for IndiansArab News
(MENAFN - Arab News) Indian pilgrims will no longer be troubled by having to pack cans of Zamzam water into their luggage when returning home after completing their Haj.As part of the arrangement ...

more...


 






Google

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country

IPO News
Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

US Markets Details

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Investment Game
Economic Calendar
Financial Glossary

My MENAFN
Portfolio Tracker

Voting

Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2000 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help